Independent register of U.S. FDA drug recalls · updated Oct 10, 2026
RxRecalls Get alerts

Is Halobetasol recalled?

Yes — there is an active recall. 2 ongoing FDA recalls mention Halobetasol (6 total). Check the affected lots below.

Most common reason: Stability / shelf life (4 of these recalls)

Recalls are matched by product description. A recall usually affects specific lots, not every package of Halobetasol. “Active” means an FDA recall is still ongoing; “closed” means it was terminated or completed. Checked against openFDA on Oct 10, 2026.

Halobetasol recalls on record

none so far in 2026; 6 on record, newest first
Class II · Moderate risk

Halobetasol Propionate Ointment 0.05% Net Wt.

CGMP Deviations: all products within expiry are being recalled because the manufacturing firm, Teligent Pharma, Inc.is discontinuing its stability study program.

Ongoing Stability / shelf life McKesson Corporation dba McKesson Drug Company NDC 63739-998-67 D-0847-2022
Class II · Moderate risk

Halobetasol Propionate Ointment

cGMP deviations: all products within expiry are being recalled because the firm is discontinuing its stability study program.

Terminated Stability / shelf life Teligent Pharma, Inc. NDC 63739-998-67 D-0691-2022
Class II · Moderate risk

Halobetasol Propionate Ointment

cGMP deviations: all products within expiry are being recalled because the firm is discontinuing its stability study program.

Terminated Stability / shelf life Teligent Pharma, Inc. NDC 52565-073-15 D-0689-2022
Class II · Moderate risk

Halobetasol Propionate Ointment

cGMP deviations: all products within expiry are being recalled because the firm is discontinuing its stability study program.

Terminated Stability / shelf life Teligent Pharma, Inc. NDC 70512-033-50 D-0688-2022
Class II · Moderate risk

Lexette (halobetasol propionate)

CGMP Deviation: Difficulty dispensing/does not dispense or dispensing liquid instead of foam.

Ongoing cGMP deviation Mayne Pharma Inc NDC 51862-604-50 D-0387-2022
Class II · Moderate risk

Halobetasol Propionate active pharmaceutical ingredient packaged…

Penicillin Cross Contamination: All lots of all products repackaged and distributed between 01/05/12 and 02/12/15 are being recalled because they were repackaged in a facility with penicillin products without adequate separation which could introduce the potential for cross contamination with penicillin.

Terminated Cross-contamination Attix Pharmaceuticals D-702-2015